Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$85.07 +2.83 (+3.44%)
At close: Oct 20, 2026 · 4:00 PM EDT

Mirum Pharmaceuticals (MIRM) Share-based Compensation (IS) (2019)

Updated

Mirum Pharmaceuticals' Share-based Compensation (IS) was $2.14 million in Q3 2019, up 30.7% from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Share-based Compensation (IS) (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Mirum Pharmaceuticals 5.41 Bn 3.82 Bn 145.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 2.14 Mn
Jun 30, 2019 1.64 Mn
API Access

Mirum Pharmaceuticals Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=MIRM&period=max&api_key=YOUR_API_KEY